Board of Regents, The University of Texas System;Memgen, LLC
发明人:
Willem W. OVERWIJK,Manisha SINGH,Patrick HWU,Mark CANTWELL
申请号：
US15772789
公开号：
US20200165339A1
申请日:
2016.11.02
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are methods and compositions for treating cancer in an individual comprising administering to the individual an effective amount of at least one immune checkpoint inhibitor and a chimeric CD 154 polypeptide. Also provided herein are methods of enhanced immune function.
